Pursuant to the terms of his offer letter, Mr. Crouch received a stock option to purchase 2,088,212 shares of Organovo’s common stock (the “Stock Option”) and a performance-based restricted stock unit award for …
Stock Option
While it would be nice to see bioprinted tissues reduce biopharma's …
The Man Upstairs
Organovo's share price fell nearly 8% at one point in after-hours trading following the news of Murphy's exit. That's to be expected. But should …
Investor
no analyst given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for ONVO is $4.50 while analysts mean recommendation is 1.60. Organovo Holdings, Inc. (NASDAQ:ONVO) …
NASDAQ
Previously, it was modeling revenue in the $4.5 million to $6.5 million range. Investors seemed unhappy with the news of Organovo's CEO …
CEO Keith Murphy
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday. Organovo (ONVO) said on Thursday that it would sell 9 million shares of common stock at $2.75 per share in …
Organovo
As investors, we’re not getting better if we’re not constantly learning, and unfortunately, lessons on Wall Street can cost a pretty penny. If you own Organovo Holdings Inc (ONVO) stock, I’d like to share an expensive …
Organovo
If there was going to be a CEO change, now was a good time to do it. 10 stocks we like better than Organovo Holdings When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the …
Leaves